ZENAS BIOPHARMA INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$28.39
-1.29%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+1.6%
3 months
-8.8%
6 months
+46.6%
1 year
-5.0%
Year to date
-21.8%
52-week range
$15.20 – $43.17
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.85B
P/E
-3.8
P/B
7.5
P/S
1,850.4
Revenue
$1M
Net income
-$484.38M
Diluted EPS
-9.62
Gross margin
100.00%
Net margin
-48438.40%
Return on equity
-189.70%
Total debt
$297.86M
Cash
$196.58M
Free cash flow
-$225.97M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1M | -$111.46M | 100.00% | -11145.60% | -$57.24M |
| Mar 31, 2026 | $0 | -$80.99M | — | — | -$75.2M |
| Dec 31, 2025 | $0 | -$240.44M | — | — | -$52.41M |
| Sep 30, 2025 | $0 | -$51.5M | — | — | -$41.13M |
| Jun 30, 2025 | $0 | -$52.22M | — | — | -$41.74M |
| Mar 31, 2025 | $10M | -$33.57M | 100.00% | -335.70% | -$37.07M |
| Dec 31, 2024 | $5M | -$52.6M | 100.00% | -1052.10% | -$38.63M |
| Sep 30, 2024 | $0 | -$38.61M | — | — | -$31.06M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ZBIO news
All market newsNo ticker-linked stories are in the current archive.